Increasing Pool of Patients Suffering from Viral Infections and the High Cost of New Drugs Are Likely to Boost the Antiviral Drugs Market
With the significant increase in the incidence of viral infections, the global antiviral drugs market is witnessing a substantial rise in its size and valuation. The increasing prevalence of chronic infections, such as HIV/AIDS and hepatitis B, which require long-term treatment, is also adding considerably to the growth of this market.
View full press release